Transient abnormal myelopoiesis (Q39558): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/2082163425
@@ Property / Canonical URI: https://id.who.int/icd/entity/2082163425 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:2A60.40
@@ Property / CURIE: CID11:2A60.40 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-2A60.40
@@ Property / Canary Token: dki-india-2A60.40 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+D61.9
@@ Property / Linked ICD 10: D61.9 / rank @@
+Normal rank

Latest revision as of 05:01, 13 August 2026

A myeloid proliferation occurring in newborns with Down syndrome. It is clinically and morphologically indistinguishable from acute myeloid leukaemia and is associated with GATA1 mutations. The blasts display morphologic and immunophenotypic features of megakaryocytic lineage. In the majority of patients the myeloid proliferation undergoes spontaneous remission.

Language	Label	Description	Also known as
default for all languages	2A60.40
English	Transient abnormal myelopoiesis	A myeloid proliferation occurring in newborns with Down syndrome. It is clinically and morphologically indistinguishable from acute myeloid leukaemia and is associated with GATA1 mutations. The blasts display morphologic and immunophenotypic features of megakaryocytic lineage. In the majority of patients the myeloid proliferation undergoes spontaneous remission.